The medical-grade cannabis company is gaining greater recognition as an investment vehicle
WeedMD Inc. is recognized as a distributor and producer of medical-grade cannabis. As part of its latest updates, it has been reported that, following HMMJ’s quarterly rebalancing, the company has been added to the Horizons Marijuana Life Sciences Index ETF (exchange-traded fund). This seems to be an important step, since it represents that the company has a return to this index of North American companies that have successfully managed to go public with a fairly significant commercial activity in relation to the cannabis industry.
For those who may not be very familiar, HMMJ is an indexed ETF whose main objective is the performance of the North American Marijuana Index, net of expenses, as long as this is possible. This Index was created with the intention of providing exposure to the performance of a basket of North American life sciences companies that are listed on the stock market and that manage to carry out commercial activities that have great relevance in the cannabis industry, something like the one that WeedMD Inc. provides.
On the other hand, WeedMD Inc. is a license holder that produces and distributes cannabis products to markets that relate to the medical use of the plant, especially for adults under treatment. In order to provide the maximum quality in its products, the company has a greenhouse with the best and most advanced technology, a 26,000-square-foot fully licensed processing facility, and an outdoor facility, specializing in the extraction of cannabis. Starseed was recently incorporated and, with this, WeedMD has been able to expand its multi-channel distribution strategy.